Literature DB >> 17186360

Breast cancer risk factors and second primary malignancies among women with breast cancer.

Amy Trentham-Dietz1, Polly A Newcomb, Hazel B Nichols, John M Hampton.   

Abstract

PURPOSE: To examine the association between breast cancer risk factors and second primary cancers (independent diagnoses occurring at least 12 months after the initial breast cancer diagnosis) among breast cancer survivors.
METHODS: In this population-based study, cancer outcomes among breast cancer survivors first diagnosed during 1987-2000 were investigated. Invasive breast cancer cases were identified from the statewide tumor registry and interviewed regarding their pre-diagnosis risk factors, including reproductive and lifestyle characteristics, approximately 1 year after diagnosis. Data on second primary cancers (not recurrences) and deaths were obtained by linkage with tumor registry reports and death certificates through December 31, 2002. Hazard ratios (HR) were estimated using proportional hazards regression stratified by age and adjusted for stage and other factors.
RESULTS: Among the 10,953 breast cancer cases, 10.8% experienced a second cancer diagnosis within an average of 7 years (including 488 breast, 132 colorectal, 113 endometrial, and 36 ovarian cancers). Risk of a second primary breast cancer increased according to low parity (P = 0.002), older age at menopause (P = 0.08), greater body mass index (P = 0.003) and adult weight gain (P = 0.02), and a family history of breast cancer-particularly among women with 2 or more first-degree affected relatives (HR = 1.8, 95% CI: 1.1-2.9). Reduced risk of colorectal cancer after breast cancer was observed in relation to older ages at menarche (P = 0.05), younger age at menopause (P = 0.04), postmenopausal hormone use (HR = 0.4, 95% CI: 0.3-0.7), normal body mass index (P = 0.07), and infrequent alcohol consumption (P = 0.01). Second endometrial cancer risk was associated with increasing body mass index (P < 0.01) and adult weight gain (P = 0.03). Risk of second ovarian cancer appeared related to recent alcohol intake and family history of breast cancer. Women who reported consuming any alcohol appeared to have a 55% reduction in ovarian cancer risk (95% CI: 0.2-1.0) compared to non-drinkers, while having 2 or more first-degree relatives with breast cancer was associated with an increased risk of ovarian cancer (HR = 4.3, 95% CI: 1.3-14.6).
CONCLUSION: This study suggests that family history of breast cancer as well as potentially modifiable characteristics including body weight, alcohol intake, and postmenopausal hormone use may be associated with risk of a second cancer diagnosis among breast cancer cases.

Entities:  

Mesh:

Year:  2006        PMID: 17186360     DOI: 10.1007/s10549-006-9446-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Authors:  Amy Trentham-Dietz; Mehmet Ali Ergun; Oguzhan Alagoz; Natasha K Stout; Ronald E Gangnon; John M Hampton; Kim Dittus; Ted A James; Pamela M Vacek; Sally D Herschorn; Elizabeth S Burnside; Anna N A Tosteson; Donald L Weaver; Brian L Sprague
Journal:  Breast Cancer Res Treat       Date:  2017-11-28       Impact factor: 4.872

2.  Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer.

Authors:  Amy L Gross; Betty J May; Jennifer E Axilbund; Deborah K Armstrong; Richard B S Roden; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-15       Impact factor: 4.254

3.  Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma.

Authors:  Sang Min Park; Tricia Li; Shaowei Wu; Wen-Qing Li; Abrar A Qureshi; Meir Stampfer; Eunyoung Cho
Journal:  Cancer Epidemiol       Date:  2017-02-24       Impact factor: 2.984

4.  Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.

Authors:  Kiyong Na; Jung-Yun Lee; Ji-Youn Sung; Gun Min Kim; Ja Seung Koo; Hyun-Soo Kim
Journal:  Virchows Arch       Date:  2018-06-20       Impact factor: 4.064

5.  An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors.

Authors:  Anne Kreklau; Ivonne Nel; Sabine Kasimir-Bauer; Rainer Kimmig; Anna Christina Frackenpohl; Bahriye Aktas
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

6.  Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.

Authors:  Jennifer A Ligibel; Ann Partridge; Anita Giobbie-Hurder; Mehra Golshan; Karen Emmons; Eric P Winer
Journal:  Ann Surg Oncol       Date:  2008-10-24       Impact factor: 5.344

Review 7.  Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.

Authors:  Lois B Travis; Wendy Demark Wahnefried; James M Allan; Marie E Wood; Andrea K Ng
Journal:  Nat Rev Clin Oncol       Date:  2013-03-26       Impact factor: 66.675

8.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.

Authors:  Julia A Knight; Leslie Bernstein; Joan Largent; Marinela Capanu; Colin B Begg; Lene Mellemkjaer; Charles F Lynch; Kathleen E Malone; Anne S Reiner; Xiaolin Liang; Robert W Haile; John D Boice; Jonine L Bernstein
Journal:  Am J Epidemiol       Date:  2009-02-11       Impact factor: 4.897

9.  Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Authors:  Louise A Brinton; Ashley S Felix; D Scott McMeekin; William T Creasman; Mark E Sherman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino
Journal:  Gynecol Oncol       Date:  2013-02-26       Impact factor: 5.482

10.  Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors:  Jennifer C Carter; Frank C Church
Journal:  PPAR Res       Date:  2009-08-06       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.